Search results
Author(s):
Rhian E Davies
,
J Dawn Abbott
Added:
3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes
Stable Angina
The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or…
View more
Author(s):
Gregory J Dehmer
Added:
3 years ago
The use of percutaneous coronary intervention (PCI) for coronary artery revascularization has grown considerably since the first balloon angioplasty in 1977. Improvements in equipment and drug therapies plus the development of coronary artery stents have all contributed to the growth of PCI as an alternative to surgical revascularization. Compared with the early days of balloon angioplasty, when…
View more
Author(s):
Despoina-Rafailia Benetou
,
Panayotis K Vlachakis
,
Charalampos Varlamos
,
et al
Added:
2 years ago
DAPT in Complex PCI
Author(s):
Dimitrios Alexopoulos
,
Charalampos Varlamos
,
Despoina-Rafailia Benetou
Added:
3 years ago
Article
Author(s):
Hans P Niendorf
,
P Lengsfeld
,
M Bräutigam
Added:
3 years ago
Contrast-induced nephropathy (CIN) in the actual essence of the term refers to renal damage induced by a contrast medium. The ultimate clinical manifestation of CIN is renal failure requiring dialysis, and this article will concentrate on CIN as a clinical outcome. However, transient rises in serum creatinine have been frequently used as a surrogate marker that is suggested to predict renal…
View more
Author(s):
Charalampos Varlamos
,
Ioannis Lianos
,
Despoina-Rafailia Benetou
,
et al
Added:
2 years ago
Author(s):
Rik Rozemeijer
,
Wijnand P van Bezouwen
,
Michiel Voskuil
,
et al
Added:
3 years ago
Dual antiplatelet therapy (DAPT) consisting of aspirin and a P2Y12 inhibitor is prescribed in the treatment of acute coronary syndrome (ACS) or following percutaneous coronary intervention (PCI) for drug-eluting stent (DES) implantation. An important misconception remains that DAPT should be prescribed to prevent stent thrombosis. Although this may seem obvious, it should be emphasized that the…
View more
Author(s):
Alexander G Truesdell
,
Matheen A Khuddus
,
Sara C Martinez
,
et al
Added:
3 years ago
“When you fail to prepare, you’re preparing to fail.”
– Coach John Wooden
Ongoing technological and procedural innovations increasingly permit the safe and effective performance of ever more high-risk and complex percutaneous coronary interventions (PCI) in the modern cardiac catheterization laboratory. Anatomic characteristics of higher risk include unprotected distal left main stenosis,…
View more
Author(s):
Mirvat Alasnag
,
Khalid Al Johani
,
Added:
9 months ago
In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization.
In this podcast, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the…
View more
Author(s):
Nicolas M Van Mieghem
Added:
6 years ago
In this video, Dr Nicolas Van Mieghem discusses which patients he is performing TAVR in now.
View more